Cancer Biology & Therapy · 2007 · 72 citations · 27 references
Life SciencesCell BiologyMolecular BiologyApoptosisCell SignalingSignal TransductionApoptotic Signal TransductionApoptotic SignalingCaspase ActivationCell DeathDeath ReceptorsSignal Transduction In CancerApoptosis Signaling In CancerApoptosis Signaling PathwaysCell Death RegulatorsCell Death Signaling PathwaysInterferon Signaling ResponsesTime-dependent Protein BindingTrail ReceptorsTrail-mediated Apoptosis
Apoptosis induced by interferon-alpha (IFNalpha) is associated with induction of TRAIL in a number of different cell types. Here we examined whether or not TRAIL was required for apoptosis in a model human bladder cancer cell line (UM-UC-12) and defined the molecular mechanisms involved in IFNalpha-induced TRAIL expression. Exposure to IFNalpha resulted in concentration-dependent induction of TRAIL and apoptosis. Inhibition of TRAIL or downstream components of the TRAIL cell death pathway (FADD, caspase-8) via siRNA-mediated knockdown attenuated IFNalpha-induced cell death, thereby implicating TRAIL in the response. IFNalpha induced rapid STAT-1 phosphorylation and DNA binding activity and subsequent accumulation of IRF-1. Transfection with siRNAs directed against STAT-1 or IRF-1 inhibited IFNalpha-induced TRAIL production and cell death, and chromatin immunprecipitation (ChIP) analyses demonstrated that IFNalpha induced direct, time-dependent binding of both transcription factors to the TRAIL promoter. Together, our results demonstrate that IFNalpha induces TRAIL expression via a STAT-1/IRF-1-dependent mechanism in human bladder cancer cells, and this induction of TRAIL plays an important role in IFNalpha-induced cell killing.
27
Molecular determinants of response to TRAIL in killing of normal and cancer cells.
Kunhong Kim, Michael J. Fisher, Shiqiong Xu et al. · PubMed · 2000 · 378 citations
Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage
Nobuyuki Tanaka, Masahiko Ishihara, Marc S. Lamphier et al. · Nature · 1996 · 327 citations
Fadi N. Joudi, Michael A. O’Donnell · Urologic Oncology Seminars and Original Investigations · 2006 · 243 citations